MENU
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PolyPid (PYPD) Earnings Date & Reports
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more
A.I. Advisor
published Earnings
PYPD is expected to report earnings to rise 11.43% to -38 cents per share on November 11
Q3'26
Est.
$-0.39
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.70
Q4'25
Missed
by $0.08
Q3'25
Missed
by $0.04
The last earnings report on August 12 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 105.81K shares outstanding, the current market capitalization sits at 103.59M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes
Industry Biotechnology
Profile
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
75
Web
https://www.polypid.com